Utilities and power generation companies are bolstering operational efficiency and plant reliability by implementing advanced ...
This agreement represents NetraMark's ninth commercial contract since the start of its current fiscal year and demonstrates growing interest in AI-enabled clinical trial analytics, like NetraAI, among ...
Not enough children in Milwaukee are being screened for lead. Kids with lead poisoning are slipping through the cracks.
Doug Wintemute is a staff writer for Forbes Advisor. After completing his master’s in English at York University, he began his writing career in the higher education space. Over the past decade, Doug ...
This agreement represents NetraMark's ninth commercial contract since the start of its current fiscal year and demonstrates growing interest in AI-enabled clinical trial analytics, like NetraAI, among ...
The Nuclear Regulatory Commission (NRC) has proposed what may be its most consequential reactor-licensing overhaul in a ...
Vistagen (Nasdaq: VTGN), a late clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product ...
Extreme heat deaths in the United States have nearly doubled since 1999, with 2,394 Americans killed in 2024 — yet federal ...
TOMAGOLD CORPORATION (TSXV: LOT; OTCPK: TOGOF) (“ TomaGold ” or the “ Company ”) is pleased to announce assay results from the first of five extension holes, TOM-25-011EXT, completed as part of Phase ...
Extreme heat deaths in the United States have nearly doubled since 1999, with 2,394 Americans killed in 2024 — yet federal ...
CNX Resources is a disciplined capital allocator, prioritizing FCF per share and aggressive buybacks over production growth. Read more on CNX stock here.
Elicio Therapeutics, Inc. (Nasdaq: ELTX) ('Elicio” or the 'Company”), a clinical-stage biotechnology company developing next-generation immunotherapies for KRAS-driven cancers, today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results